PROTECT PHARMACEUTICAL Corp: 10-Q filed 2019-02-07
What PROTECT PHARMACEUTICAL Corp reported in its quarterly report filed 2019-02-07 (fiscal Q2 2017): 16 published measures, 39 facts as tagged in accession 0001493152-19-001537.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-02-07
- Fiscal period
- fiscal Q2 2017
- Accession
- 0001493152-19-001537 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PROTECT PHARMACEUTICAL Corp filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 0 | USD | |
| At 2016-12-31 | 0 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 136,563 | USD | |
| At 2016-12-31 | 20,830 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | -136,563 | USD | |
| At 2016-12-31 | -20,830 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -100,333 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -115,733 | USD | 181 |
| 2016-04-01 to 2016-06-30 | -10,458 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -14,130 | USD | 182 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-06-30 | -8,560 | USD | 182 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-06-30 | 8,840 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | -9,507,732 | USD | |
| At 2016-12-31 | -9,391,999 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 1,500 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 3,000 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -100,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -115,400 | USD | 181 |
| 2016-04-01 to 2016-06-30 | -10,458 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -14,130 | USD | 182 |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 333 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 333 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 36,230 | USD | |
| At 2016-12-31 | 20,830 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 100,000 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 115,400 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 10,458 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 14,130 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 1,111,460 | shares | |
| At 2016-12-31 | 1,111,460 | shares |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -100,333 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -115,733 | USD | 181 |
| 2016-04-01 to 2016-06-30 | -10,458 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -14,130 | USD | 182 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | 200 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 103 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 195 | USD | 182 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | -9,000 | USD | 181 |
| 2016-01-01 to 2016-06-30 | 2,570 | USD | 182 |
Inspect the source
- Entity
- PROTECT PHARMACEUTICAL Corp / CIK 0001493526
- Captured
- SEC response SHA-256
bf1ce86f3a2d5eb5f9d9f7f0fbe211675520a0792f638ea498f1809d5f6f06c8
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001493526.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))